Modules:Retinal Degeneration: Difference between revisions

From OpenWetWare
Jump to navigationJump to search
No edit summary
No edit summary
Line 49: Line 49:
| arRP
| arRP
|--
|--
| September 12
| Mouse ''rd2''
| Jane Smith
| Natural
| Setting up a course homepage
| ''Prph2rd2''
| [[Help:Hosting_courses#Set_up_your_course_homepage|Course homepage]]
| Outer segment malformation
| RP, AMD
|--
|--
| September 14
| Mouse ''sh-1''
| Jane Smith
| Natural
| Creating a people page
| ''Myo7a''
| [[OWW.101:People]]
| Usher Syndrome Type B
| arRP
|--
|--
| September 19
| Mouse ''orJ''
| Jane Smith
| Natural
| Formatting a course schedule
| ''Chx10''
| [[OWW.101:Schedule]]
| Retinal Hypcellularity
| Microthalmia
|--
| Rat ''RCS''
| Natural
| ''Mertk''
| Subretinal space debris stress
| arRP
|--
| Chicken rd ''orJ''
| Natural
| ''Gucy1''
| Rod/Cone cGMP depression
| rLCA type I
|--
| Briard Dog
| Natural
| ''RPE65''
| Retinoid metabolism failure
| LCA type II
<!-- To add another row to the table copy and paste everything from the |-- line to just above this line.-->
<!-- To add another row to the table copy and paste everything from the |-- line to just above this line.-->
|}
|}

Revision as of 23:32, 10 January 2010

Science Knowledge Modules

Retinal Degeneration        Retinal Circuits        Opsins        Gene Regulation        Gene Therapy       

Photoreceptor degeneration in humans results from retinal diseases such as retinitis pigmentosa and age-related macular degeneration. Photoreceptor cell death is accompanied by changes in the neural retina (Banin et al., 1999; Peng et al., 2000; Strettoi and Pignatelli, 2000; Aleman et al., 2001; Strettoi et al., 2002; Strettoi et al., 2003). The local functional implications are not well understood but could compromise spatial processing and transform the retina into a self-signaling neural assembly(Marc and Jones, 2003), making it difficult to use microelectronic retinal prostheses as a rescue strategy. Genetic rescue techniques have there challenges but have windows of opportunity during the degenerative process (Marc and Jones, 2003).


Robert Marc's Stages of Degeneration

Progressive vision loss in any dog in the absence of canine glaucoma or cataracts can be an indication of PRA. It usually starts with decreased vision at night, or nyctalopia. Other symptoms include dilated pupils and decreased pupillary light reflex. Fundoscopy to examine the retina will show shrinking of the blood vessels, decreased pigmentation of the nontapetal fundus, increased reflection from the tapetum due to thinning of the retina, and later in the disease a darkened, atrophied optic disc. Secondary cataract formation in the posterior portion of the lens can occur late in the disease. In these cases diagnosis of PRA may require electroretinography (ERG). For many breeds there are specific genetic tests of blood or buccal mucosa for PRA.[1]

Retinal Degeneration in Humans

There are 161 known gene defects that result in photoreceptor degeneration (Punzo and Cepko, 2007). Rods are primary targets of these mutations (e.g., RP) and different mutations in a single gene can lead to very different progressions of degeneration (Sung et al., 1994). Retinal degeneration can be cone initiated as well (e.g., ARMD). Cone (COD), Cone-Rod Dystrophy (CORD), and Leber’s Congenital Amaurosis (LCA) can all be initiated by defects in the same genes (Wells et al., 1993). RPE gene defects are also known to lead to photoreceptor degeneration (Marc and Jones, 2003).

Animal Models of Retinal Degeneration

> 90% of the human retina is identical to all experimental mammalian retinae in terms of cone density, structure, and molecular signatures of each cell type (Marc and Jones, 2003).

Model Occurance Gene Cellular Phenotype Human Phenotype
Mouse rd1 Natural PDE6Brd1 Rod cGMP elevation arRP
Mouse rd2 Natural Prph2rd2 Outer segment malformation RP, AMD
Mouse sh-1 Natural Myo7a Usher Syndrome Type B arRP
Mouse orJ Natural Chx10 Retinal Hypcellularity Microthalmia
Rat RCS Natural Mertk Subretinal space debris stress arRP
Chicken rd orJ Natural Gucy1 Rod/Cone cGMP depression rLCA type I
Briard Dog Natural RPE65 Retinoid metabolism failure LCA type II




Rod-cone dysplasia

This type of PRA has an early onset of severe vision loss. It is caused by a defect in the gene for cGMP-phosphodiesterase, which leads to retinal levels of cyclic guanosine monophosphate ten times normal.[2]

Rod-cone dysplasia type 1

  • Irish Setter - Rod cell response is nearly absent. Night blindness by six to eight weeks old, often blind by one year old.[3]
  • Sloughi[4] - A DNA test can identify whether Sloughis have the mutated recessive gene. This has enabled breeders to breed away from PRA, and the disease is now rare in the breed.

Rod-cone dysplasia type 2

  • Collie - Rod cell response is nearly absent. Night blindness by six weeks old, blind by one to two years old.[3]

Rod-cone dysplasia type 3

Rod dysplasia

  • Norwegian Elkhound - Characterized by dysplasia of the rod cell unit and subsequent degeneration of the cone cell unit. Rod cell response is nearly absent. Night blindness by six months old, blind by three to five years old. Rod dysplasia has now been bred out of this breed.[3]

Early retinal degeneration

  • Norwegian Elkhound - Night blindness by six weeks old, blind by twelve to eighteen months old.[3]

Photoreceptor dysplasia

This is caused by an abnormal development of both rod and cone cells. Dogs are initially night blind and then progress to day blindness.

Cone degeneration

  • Alaskan Malamute - Temporary loss of vision in daylight (hemeralopia) at eight to ten weeks old. There is a purely rod cell retina by four years old.[3]

Progressive rod-cone degeneration (PRCD)

This is a disease with normal rod and cone cell development but late onset degeneration of the rod cells that progresses to the cone cells. It is inherited as an autosomal recessive trait and has been linked to the ninth canine chromosome.[4]

X-linked PRA

This condition is linked to the X chromosome.

  • Siberian Husky - Night blindness by two to four years old.[3]
  • Samoyed - More severe disease than the Husky.[4]

Dominant PRA

Feline PRA

  • Abyssinian - Two forms exist. One is inherited as an autosomal dominant trait and has an early age onset. The other is inherited as an autosomal recessive trait and has a middle age onset.[4]
  • Early onset PRA has also been reported in the domestic shorthaired cat and Persian. The Siamese also likely has a hereditary form of PRA.[5] Despite belief among breeders to the contrary, there is apparently no link between coat color in Persians and the development of PRA.[6]

Central progressive retinal atrophy (CPRA)

CPRA is also known as retinal pigment epithelial dystrophy (RPED). The cause of this condition is the loss of the retinal pigment epithelium's ability to effectively process the photoreceptor outer segment (POS) and subsequent accumulation of POS material in the RPE and loss of function. The loss of function of the RPE leads to photoreceptor degeneration.[2] Vitamin E deficiency may play a role in the development of CPRA.[7] It is characterized by accumulation of pigment spots in the retina surrounded by retinal atrophy and a mottled appearance of the pigmented nontapetal fundus. The pigmented spots eventually coalesce and fade as the atrophy of the retina increases. It is an inherited condition (in the Labrador Retriever it is inherited as an autosomal dominant trait with variable penetrance).[1] CPRA occurs in older dogs. Peripheral vision is retained for a long time. Vision is better in low light and better for moving or distant objects. Not all affected dogs go blind. Secondary cataracts are common.

Commonly affected breeds

It can also be found in the poodle varieties

Hereditary retinal dysplasia

There is another retinal disease in Briards known as hereditary retinal dysplasia. These dogs are night blind from birth, and day vision varies. Puppies affected often have nystagmus. It is also known as lipid retinopathy.[3]

See also

References

  1. 1.0 1.1 Cite error: Invalid <ref> tag; no text was provided for refs named Merck
  2. 2.0 2.1 http://en.wikipedia.org/wiki/Oil-drop_experiment
  3. 3.0 3.1 3.2 3.3 3.4 3.5 3.6 3.7 3.8 3.9 Cite error: Invalid <ref> tag; no text was provided for refs named Gelatt_1999
  4. 4.0 4.1 4.2 4.3 4.4 4.5 4.6 Cite error: Invalid <ref> tag; no text was provided for refs named Petersen
  5. Template:Cite journal
  6. Template:Cite journal
  7. Template:Cite journal

de:Progressive Retinaatrophie